bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Prelude Therapeutics logo

    Prelude Therapeutics

    PRLD | NASDAQ
    Chart Builder DCF Calculator
    $4.70
    -$0.17 (-3.49%)
    At close: Sep 21, 2026, 4:00 PM ET
    $4.70
    $0 (0.00%)
    Pre-market: Sep 22, 2026, 8:30 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $267.58M
    Enterprise Value
    $133.48M
    Beta
    0.96
    Average Volume
    470.6K
    Shares Outstanding (Diluted)
    98.39M
    Shares Change YoY
    29.47%
    Institutional Ownership
    37.29%
    Exchange
    NASDAQ
    ISIN
    US74065P1012

    Price Performance

    Price Change 1M
    -29.1%
    Price Change 3M
    7.3%
    Price Change 6M
    44.2%
    Price Change YTD
    72.2%
    Price Change 1Y
    365.4%
    Price Change 3Y
    67.3%
    Price Change 5Y
    -86.4%
    1M CAGR (ann.)
    -4.1%
    1Y CAGR (ann.)
    365.4%
    5Y CAGR (ann.)
    -31.9%
    All-Time CAGR
    -24.9%

    Valuation

    PE Ratio
    -5.95
    Forward PE
    34.64
    PEG Ratio
    -0.07
    Forward PEG
    0.24
    PS Ratio
    11.93
    Forward PS
    6.40
    PB Ratio
    2.00
    P/FCF Ratio
    -8.05
    P/Adj. FCF Ratio
    -6.44
    P/OCF Ratio
    -13.82
    EV/Sales
    5.95
    EV/EBIT
    -2.21
    EV/EBITDA
    -2.27
    EV/FCF
    -4.01
    Earnings Yield
    -16.8%
    FCF Yield
    -12.4%
    Adj. FCF Yield
    -15.5%

    Financial Health

    Net Cash
    $134.11M
    Total Debt
    $17.65M
    Cash & Short-Term Investments
    $151.76M
    Total Assets
    $189.36M
    Current Ratio
    4.07
    Quick Ratio
    4.07
    Debt / Equity Ratio
    0.13
    Debt / EBITDA
    -0.30
    Debt / FCF
    -0.53
    OCF / Debt
    -1.88
    Interest Coverage
    0.00
    Altman Z-Score
    -2.54
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    98.3%
    Operating Profit Margin
    -300.6%
    EBITDA Margin
    -262.7%
    Net Profit Margin
    -269.8%
    FCF Margin
    -148.3%
    Adj. FCF Margin
    -185.3%
    SBC / Revenue
    37.0%
    SBC Impact (per share)
    -24.9%

    Returns

    Return on Assets
    -31.9%
    Return on Equity
    -75.3%
    Return on Invested Capital
    -43.7%
    Return on Capital Employed
    -44.5%
    Return on Tangible Assets
    -31.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    114.3%
    Revenue CAGR 5Y
    88.1%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    36.1%
    EPS CAGR 5Y
    22.2%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    44.2%
    FCF CAGR 5Y
    12.4%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    8
    EPS Growth Next 3Y
    42.6%
    Revenue Growth Next 3Y
    64.6%
    Earnings Date
    Nov 10, 2026
    EPS Estimate (next Q)
    -$0.16
    EPS Growth Est (next Q)
    -38.5%
    Revenue Est (next Q)
    $27.75M
    Revenue Growth Est (next Q)
    326.9%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $8
    Price Target Upside
    70.2%

    Cash Flow

    Operating Cash Flow
    $-33.26M
    Free Cash Flow
    $-33.26M
    Adj. Free Cash Flow
    $-41.55M
    FCF Per Share
    -$0.34
    OCF Per Share
    -$0.34
    OCF/S Ratio
    -148.3%

    Income Statement

    Revenue
    $22.42M
    Gross Profit
    $22.03M
    Operating Income
    $-67.4M
    EBITDA
    $-58.9M
    Net Income
    $-60.49M
    EPS (Diluted)
    -$0.79
    Revenue / Employee
    $283.85K
    Profit / Employee
    $-765.67K
    Employees
    79

    © 2026 bestshares.com. All rights reserved.